When pain goes weird : Central sensitisation and its implications for physiotherapy practice by van Griensven, Hubert
14 Articles • In Touch • Autumn 2015 • No 152
When pain goes weird: central sensitisation 
and its implications for physiotherapy practice 
Introduction
When I trained as a physiotherapist in The Netherlands, the role of 
the nervous system was discussed frequently. We were discouraged 
from thinking about pain purely as a phenomenon that originated 
in, was maintained by and could be treated through the 
musculoskeletal tissues. Once I started working it became clear 
that this view was far from common. I once taught on in-service 
training about the sensory nervous system and colleagues asked 
whether I invented these different neurones just to make a point!
I realised that I was not alone when, in 1997, I attended a two-day 
lecture series by Louis Gifford entitled The Clinical Biology of Aches 
and Pains. Here was a man who had studied neural and endocrine 
physiology, psychology and musculoskeletal physiotherapy in 
order to make sense of pain. He was a highly reflective practitioner 
who asked himself how consistent our practice was with modern 
science. He used the answers he found to empower rather than 
belittle physiotherapists, putting them straight on some opinions 
and practices while encouraging them to capitalise on others. He 
presented practitioners with an integrative framework to enable 
them to deal with pain on a rational basis. My interest in the nervous 
system was rekindled and became the basis of my practice.
With regard to pathobiology, Louis pointed to clinical reasoning 
categories (Jones 1995) and extended them to include the 
nervous system; input from the tissues, processing by peripheral 
neurones, processing by the central nervous system, and output 
through efferent systems including autonomic and endocrine. He 
urged us to make a reasoned hypothesis of the contribution in 
each category for every patient, and, if we could not achieve this, 
either to find out more from the patient or gain more knowledge. 
In other words, he suggested that we make all features fit 
(Maitland 1986) and deal with the consequences.
Plasticity in the central sensory nervous system is one of the 
factors that may prevent us from making the musculoskeletal 
features fit in patients with persistent pain. Under normal 
circumstances, there is a reliable correlation between what the 
patient perceives and what is happening in their somatic body; 
pressure, tissue damage, cooling, etc. In this situation, the sensory 
nervous system can be viewed as a simple conduit between the 
tissues and the brain. Clinically, this means that the patient’s 
descriptions of their sensations offer a relatively direct window 
on the state of the tissues. However, the patient’s presentation 
is influenced by a number of subjective factors (Glenton 2003; 
May et al 2000; Osborn & Smith 1998; Toye & Barker 2010) 
and persistent pain is associated with changes in how the 
central nervous system processes sensory information. This 
phenomenon, sometimes referred to as central sensitisation, leads 
to exaggerated pain responses and pain in physically unaffected 
body regions (Latremoliere & Woolf 2009). In Louis’ words, when 
plasticity starts to get involved, “the pain goes weird.”
Basic pain neurophysiology
Information about the somatic body is conveyed to the central 
nervous system through activation of receptors in the tissues 
and their sensory neurones. Receptors may be specialised for 
a specific stimulus or polymodal, and can be subdivided into 
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Learning outcomes
1 Understand sensory processing, both under normal 
and pathological circumstances.
2 Understand the principles for assessment, 
management and treatment of patients thought to 
have central factors contributing to their pain.
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nociceptive, i.e. activated by noxious stimuli, and non-nociceptive. 
Generally, non-noxious mechanical stimuli such as stretch or 
pressure are activate sets of highly specialised receptors and 
transmitted by their thick and fast conducting myelinated A  fibres 
(Gardner & Johnson 2013a, 2013c).
Nociceptive neurons, type A! or C, have a high stimulation 
threshold and generally respond only to stimuli associated 
with actual or potential tissue damage. Thin, but myelinated A! 
fibres respond and accommodate quickly, thus providing a quick 
first response to noxious input due to injury. The fast response 
characteristics provide discriminatory information about location 
and duration of the problem, also referred to as first pain. On 
the other hand, thin and unmyelinated C fibres respond and 
accommodate more slowly and provide a second pain which is 
more dull and aching in nature (van Cranenburgh 2000). These 
response characteristics are observed in experimental acute 
pain; persistent inflammation lowers the stimulation threshold 
of both types of nociceptor, manifesting as primary or peripheral 
hyperalgesia. Hyperalgesia is defined as increased pain from a 
response that normally provokes pain (www.iasp-pain.org).
Figure 1: Representation of three sensory pathways from periphery 
(left), via the dorsal horn (middle) to brain (right).Some A  and C 
fibres enter the spinal cord and synapse with nociception-specific 
neurones (NSN) which ascend to the thalamus via the spino-
thalamic tract (STT). Others synapse with wide dynamic range cells 
(WDR) via a network of interneurones (INN) which project to the 
medulla or the thalamus via the spino-reticular tract (SRT) or the 
STT. A! fibres ascend via the dorsal column (DC) to the medulla, but 
also have branches that influence WDR and IIN
Simplifying spinal cord neurology for the sake of clarity, we can 
identify three main sensory pathways as shown in figure 1 (Galea 
2013; Gardner & Johnson 2013b). Some A! and C fibres synapse 
with secondary nociception-specific neurones (NSN), which cross 
the midline and ascend to the thalamus via the spino-thalamic 
tract (STT). Others synapse with a network of interneurones which, 
in turn, connect with neurones that follow either the STT or go to 
the medulla via the spino-reticular tract (SRT) (Basbaum & Jessell 
2013). An important set of these neurones respond to both non-
noxious A  stimulation and nociceptive input and are therefore 
called wide dynamic range (WDR) cells. Finally, although A  fibres 
ascend directly in the dorsal column to synapse in the medulla, 
they have branches into the spinal cord at the level of entry. These 
branches synapse with the WDR via the interneurones (ibid). This 
link is thought to form the physiological substrate for allodynia, 
the production of pain due to a stimulus that does not normally 
produce pain (www.iasp-pain.org).
Primary sensory neurones terminate in the dorsal horn. The 
main excitatory neurotransmitter released by nociceptive and 
non-nociceptive primary neurones is glutamate, which opens 
ion channels of the AMPA (a-amino-3-hydroxyl-5-methyl-4-
isoxazole-propionate) type in the post-synaptic membrane. This 
leads to depolarisation of the secondary neurone and therefore 
transmission of the signal. The dorsal horn also contains a 
large population of inhibitory interneurones (IIN), which when 
stimulated can release inhibitory neurotransmitters such as 
glycine and "-aminobutyric acid (GABA). These transmitters have 
a moderating effect on nociceptive transmission in several ways 
(Sandkühler 2009, 2013) as illustrated in figure 2. When there is 
no noxious stimulation, the response of nociceptive neurones is 
kept under control (muting). When there is, IIN limit the response 
of the secondary neurone (attenuation). The input from adjacent 
neurones is also controlled, thus preventing spreading excitation 
from both nociceptive and non-nociceptive neurones which would 
manifest as spreading hyperalgesia and allodynia (separating and 
localising). Finally, stimulation of A  fibres can have an inhibitory 
effect on nociceptive transmission, as described in the gate theory 
(Mendell 2014; Wall 1978).
Figure 2: Representation of three inhibitory mechanisms at spinal 
cord level:
1) When a nociceptive fibre is stimulated, it activates inhibitory 
interneurones (IIN) which limit the response of the secondary 
neurone.
2) The input from adjacent neurones is also controlled to prevent 
spreading excitation.
3) Stimulation of A! fibres inhibits nociceptive transmission
A further controlling influence on nociceptor activity in the dorsal 
horn is descending inhibition, the attenuation of the activity of 
dorsal horn transmission and activity by neurones descending from 
the medulla (Heinricher & Fields 2013; Villanueva & Fields 2004). 
Medullary centres involved in this include the peri-aquaductal grey 
(PAG), rostral ventromedial medulla (RVM) and the locus coeruleus 
(LC), which respond to nociceptive input. They also respond to 
input from higher centres, for instance under stressful conditions 
(ibid). As a consequence, higher centres are able to control the 
amount of nociceptive information that is transmitted through the 
dorsal horn; the brain selects and de-selects its own information. 
On the other hand, the opposite process of descending facilitation 
has been implemented in the development of hyperalgesia and 
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allodynia in inflammation and neuropathy (Gardell et al 2003; 
Heinricher & Fields 2013).
Modern understanding of sensory physiology makes it clear that 
the perception of pain is not a passive process, but one which is 
normally carefully controlled in several ways. Nociceptive neurones 
have high stimulation thresholds and normally respond only to 
extreme stimuli. Inhibitory cells in the spinal cord limit nociceptive 
activation, both temporally and spatially. Descending systems 
also exert an inhibitory influence on nociceptive transmission in 
the dorsal horn. As a consequence, the absence of pain is likely 
to be the result of constant active control of nociceptive input, 
rather than the absence of any noxious events. In the course of 
the day several minor aches and pains can be experienced, but 
the nervous system suppresses these. However, under certain 
circumstances these moderating influences become less effective 
and facilitate the development of central sensitisation.
Central sensitisation  
at the dorsal horn
The International Association for the Study of Pain (IASP) 
defines central sensitisation as an “increased responsiveness 
of nociceptive neurons in the central nervous system to their 
normal or subthreshold afferent input” (www.iasp-pain.org). 
The notes, with the definition, explain how central sensitisation 
involves neurones in the central nervous system, i.e. not the 
primary neurone coming in from the periphery. The term “central 
sensitisation” is also referred to as long term potentiation of 
synaptic transmission strength (Ruscheweyh et al 2011). It 
applies to neurophysiological conditions but is thought to underlie 
clinical hypersensitivity of various kinds. One aspect of central 
sensitisation is that the stimulation threshold of secondary 
neurones comes down. These neurones now begin to respond to 
peripheral impulses that are normally insufficient to generate an 
action potential. This is referred to as unmasking of sub-threshold 
stimuli. A second aspect of central sensitisation is an increase 
in response to stimuli that are above the stimulation threshold 
already. Finally, central sensitisation can involve spontaneous 
neural discharges and increases in receptive field size. The overall 
effect is one of synaptic strengthening; the signals passed on 
by the secondary neurone are no longer in proportion with the 
incoming information, because the responsiveness of the synapse 
is enhanced. Clinically, this means that the pain is no longer an 
effective protective signal, but that it becomes maladaptive.
It may be helpful to divide the processes that lead to central 
sensitisation into peripheral input, descending input from higher 
centres and changes in dorsal horn cells (Woolf 2014). Peripheral 
drivers include sustained barrages of primary nociceptive input 
which lead to increased excitability of the secondary neurone. 
Descending influences may either be reduced inhibition or 
enhanced facilitation. Local changes include activation of glial 
cells and astrocytes, which may in turn facilitate sensitisation. 
These processes have been shown to contribute to the pain of 
persistent inflammation or nerve damage (Latremoliere & Woolf 
2009).
Once central sensitisation is established, only low levels of 
C-fibre activity are required to maintain it (Koltzenburg et al 
1992). The initial process constitutes a strengthening of the 
synaptic transmission between the stimulated nociceptive 
neurone and its secondary neurone or homosynaptic 
potentiation as shown in figure 3 (Woolf 2011). Secondary 
neurones, however, receive input from many neurones. Normally 
the contributions of these neurones are controlled by the action 
of IIN, but when inhibitory activity is reduced, the activation of 
adjacent primary neurones can also contribute (heterosynaptic 
potentiation). The contribution of adjacent nociceptive fibres is 
thought to underlie spreading hyperalgesia, and the contribution 
to A  fibres to allodynia.
Figure 3: Representation of potential changes in synaptic 
transmission as part of central sensitisation. 
a) Under normal circumstances, activation of the wide dynamic 
range cells (WDR) corresponds with stimulation of one of its 
nociceptive neurones. Input from adjacent neurones is controlled via 
inhibitory interneurones IIN.
b) When the secondary neurone is sensitised, adjacent nociceptive 
and A  neurones contribute to the WDR’s response
The mechanisms required for the onset of central sensitisation 
have been described in a number of texts such as Sandkühler 2013. 
When activated, primary nociceptive neurones release glutamate 
at their terminal in the dorsal horn. There it has a number of 
effects on the secondary neurone. As mentioned, glutamate 
opens AMPA ion channels which let sodium ions flow into the cell, 
leading to depolarisation (figure 4). It also opens NMDA 
(N-methyl-d-aspartate) ion channels which would let calcium 
ions in, if it were not for the fact that they are normally blocked by 
a magnesium ion. This positively charged magnesium ion is held 
in place by the negative intracellular charge. Sustained intensive 
stimulation leads to a sufficiently low potential across the 
membrane potential, the magnesium ion is no longer held in 
place, thus opening the NMDA channels. The resultant influx of 
a)
b)
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calcium ions leads to a number of intracellular reactions. The 
overall effect of these is that the secondary neurone responds to 
stimulation for longer and that the function of the ion channels is 
enhanced. The unblocking of NMDA and the effects of raised 
levels of intracellular calcium are thought to be key components 
of central sensitisation. This effect is further enhanced by the 
binding of glutamate to kainate receptors (Lerma & Marques 
2013), which further enhance the response characteristics of the 
secondary neurone.
Figure 4: Representation of the role of NMDA receptors in the 
development of central sensitisation.
a) Release of glutamate opens AMPA channels in the secondary 
neurone. The influx of Na+ ions lowers the membrane potential, 
leading to depolarisation. NMDA receptors remain blocked by Mg2+ 
ions.
b) Persistent lowering of the membrane potential removes the Mg2+ 
block.
c) Raised Ca2+ levels lead to a chain of intracellular reactions 
which enhances the function of the ion channels
It is likely that a number of additional neurotransmitters are 
involved in the sensitisation of spinal cord neurones. Their precise 
role is as yet unclear (Sandkühler 2013). One such transmitter is 
the neuropeptide substance P (SP), which may be co-released on 
strong C fibre stimulation. SP is thought to bind to the neurokinin-1 
receptor (NK1) (Porreca 2012) and has been implicated in the 
enhancement of response characteristics of the secondary 
neurone (Basbaum & Jessell 2013; Porreca 2012). 
Whether central sensitisation is maintained over longer periods 
depends in part on processes in the cell body (Salter 2012). The 
influx of calcium and activation of receptors such as NK1, leads to 
intracellular changes which are signalled to the neurone’s nucleus 
via axonal transport. The nucleus is where genes are transcribed 
to produce proteins and this production is altered in response to 
the chemical signals received from the dorsal horn. The proteins, 
including those which will form receptors and ion channels once 
they reach their target, are transported down the neurone. The 
altered proteins can therefore lead to a longer lasting change in 
response characteristics of the secondary neurone.
Further maintenance of central sensitisation comes from the 
activation of astrocytes and microglia, collectively referred to 
as glia. These cells used to be thought of as inert “packing” 
cells, but it is now clear, as illustrated in figure 5, that they 
can become “activated” by nociceptive activity (McMahon & 
Malcangio 2009). 
Figure 5: Representation of the role of glia in central sensitisation. 
Neurotransmitters released in nociceptive transmission activate glial 
cells, which in turn release cytokines and transmitters that alter the 
secondary neurone’s response characteristics
In their activated state glia release cytokines and 
neurotransmitters, which have a number of effects on synaptic 
transmission. For example, release of some cytokines can 
enhance the efficacy and number of several types of receptors 
(Milligan & Watkins 2009; Salter 2012). Glia envelop the dorsal 
horn neurones, so this release has a direct impact on signal 
transmission in the dorsal horn (Milligan & Watkins 2009). It is 
however worth bearing in mind that the glial response is complex 
and is likely to have positive functions as well (McMahon & 
Malcangio 2009; Milligan & Watkins 2009).
Clinical implications of central 
sensitisation for physiotherapy practice
Central sensitisation has been implicated in the development 
of pain in patients with rheumatoid arthritis, osteoarthritis and 
fibromyalgia syndrome (FMS) (Lee et al 2011; Meeus et al 
2012). Patients with conditions such as FMS and chronic fatigue 
syndrome often display sensitivity to a range of stimuli including 
bright light, noise, touch and temperature, so asking about 
these in the subjective examination can provide information 
about possible central sensitisation (Geisser et al 2008; Nijs 
et al 2010). Changes in central processing also have a strong 
genetic component (Woolf 2011), so questions about a history of 
other pain problems that the patient and their immediate family 
experience may be equally informative (Clauw 2012). Examples 
include dysmenorrhea, migraines, persistent musculoskeletal 
pains and irritable bowel syndrome. It may also be helpful to 
a)
b)
c)
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identify potential drivers of sensitisation, including any influences 
which may interfere with the patient’s ability to focus their 
attention away from their pain by activating their descending 
inhibitory systems (Bushnell et al 2004). 
If subjective examination identifies a number of factors 
suggestive of central sensitisation, this ought to be investigated 
further. Assessment of the somatic tissues alone is likely to 
provide only a very partial picture, so the processing status of the 
central nervous system must also be tested. It is recommended 
that sensory and other neurological tests are included in the 
examination (Watson et al 2009). Nijs et al (2010) recommend 
testing sensitivity to a range of stimuli, both local to the 
painful area and at distant sites. This can demonstrate whether 
hyperaesthesia, hyperalgesia and allodynia are present, and to 
what extent they are well-localised to the somatic origins of the 
pain or more widespread. 
If the patient is thought to have a strong component of central 
sensitisation, patient education is essential. For a detailed 
review and guidance see Nijs et al 2012. As mentioned in the 
introduction, central phenomena make persistent pain “go weird”, 
so patients should understand that this is a function of their pain 
processing system, not their psychology, and only partially their 
somatic body. Several qualitative studies have found that patients 
with persistent pain feel disbelieved and written off (Corbett et al 
2007; Holloway et al 2007; Osborn & Smith 1998). Providing a 
realistic explanation can help the patient to make sense of their 
pain and “normalise” it for themselves (Dowrick 2004).
When it comes to treatment or management of the pain, it may 
be helpful to consider the factors that either drive or inhibit 
central sensitisation. Reducing contributing factors may include 
treating the tissues or providing medication with the overt aim of 
influencing the function of the central nervous system. However, 
in patients with persistent pain this has often proved inefficient. 
Adjuvant medication may address central components of the pain 
(Smith & Muralidharan 2013). Physiotherapists may consider 
ways of maximising inhibition, using strategies such as general 
exercise (Daenen et al 2015; Foster et al 2013), mindfulness 
(Grabovac et al 2011), or selective A  stimulation through 
manual therapy or TENS (Johnson & Paley 2013; McCarthy 2013). 
Whatever treatment strategy is selected, the overall aim is to 
enhance the inhibition of central pain processes rather than the 
mere reduction of nociceptive input in the periphery.
Conclusion
Under normal circumstances, timing and intensity of physical 
stimuli is transmitted proportionally by the sensory nervous 
system. Several inhibitory mechanisms keep this transmission 
under control. However, persistent inflammation and neuropathy 
can reduce this control and alter nociceptive transmission in 
the dorsal horn. The patient’s pain is out of proportion with the 
original injury and becomes less predictable and less easy to 
control. It is up to the physiotherapist to determine whether the 
patient’s sensory nervous system may be in a controlled state or a 
sensitised state.
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